Literature DB >> 27804917

A review of Raman spectroscopy advances with an emphasis on clinical translation challenges in oncology.

Michael Jermyn1, Joannie Desroches, Kelly Aubertin, Karl St-Arnaud, Wendy-Julie Madore, Etienne De Montigny, Marie-Christine Guiot, Dominique Trudel, Brian C Wilson, Kevin Petrecca, Frederic Leblond.   

Abstract

There is an urgent need for improved techniques for disease detection. Optical spectroscopy and imaging technologies have potential for non- or minimally-invasive use in a wide range of clinical applications. The focus here, in vivo Raman spectroscopy (RS), measures inelastic light scattering based on interaction with the vibrational and rotational modes of common molecular bonds in cells and tissue. The Raman 'signature' can be used to assess physiological status and can also be altered by disease. This information can supplement existing diagnostic (e.g. radiological imaging) techniques for disease screening and diagnosis, in interventional guidance for identifying disease margins, and in monitoring treatment responses. Using fiberoptic-based light delivery and collection, RS is most easily performed on accessible tissue surfaces, either on the skin, in hollow organs or intra-operatively. The strength of RS lies in the high biochemical information content of the spectra, that characteristically show an array of very narrow peaks associated with specific chemical bonds. This results in high sensitivity and specificity, for example to distinguish malignant or premalignant from normal tissues. A critical issue is that the Raman signal is often very weak, limiting clinical use to point-by-point measurements. However, non-linear techniques using pulsed-laser sources have been developed to enable in vivo Raman imaging. Changes in Raman spectra with disease are often subtle and spectrally distributed, requiring full spectral scanning, together with the use of tissue classification algorithms that must be trained on large numbers of independent measurements. Recent advances in instrumentation and spectral analysis have substantially improved the clinical feasibility of RS, so that it is now being investigated with increased success in a wide range of cancer types and locations, as well as for non-oncological conditions. This review covers recent advances and continuing challenges, with emphasis on clinical translation.

Entities:  

Mesh:

Year:  2016        PMID: 27804917     DOI: 10.1088/0031-9155/61/23/R370

Source DB:  PubMed          Journal:  Phys Med Biol        ISSN: 0031-9155            Impact factor:   3.609


  24 in total

Review 1.  Challenges and opportunities in clinical translation of biomedical optical spectroscopy and imaging.

Authors:  Brian C Wilson; Michael Jermyn; Frederic Leblond
Journal:  J Biomed Opt       Date:  2018-03       Impact factor: 3.170

2.  Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesions.

Authors:  Julietta V Rau; Marco Fosca; Valerio Graziani; Chiara Taffon; Massimiliano Rocchia; Marco Caricato; Paolo Pozzilli; Andrea Onetti Muda; Anna Crescenzi
Journal:  Sci Rep       Date:  2017-11-02       Impact factor: 4.379

3.  Nanosphere Lithography on Fiber: Towards Engineered Lab-On-Fiber SERS Optrodes.

Authors:  Giuseppe Quero; Gianluigi Zito; Stefano Managò; Francesco Galeotti; Marco Pisco; Anna Chiara De Luca; Andrea Cusano
Journal:  Sensors (Basel)       Date:  2018-02-25       Impact factor: 3.576

Review 4.  Optical techniques for cervical neoplasia detection.

Authors:  Tatiana Novikova
Journal:  Beilstein J Nanotechnol       Date:  2017-09-06       Impact factor: 3.649

Review 5.  Raman Spectroscopy and Imaging for Cancer Diagnosis.

Authors:  Sishan Cui; Shuo Zhang; Shuhua Yue
Journal:  J Healthc Eng       Date:  2018-06-07       Impact factor: 2.682

6.  Discrimination of breast cancer from benign tumours using Raman spectroscopy.

Authors:  Fiona M Lyng; Damien Traynor; Thi Nguyet Que Nguyen; Aidan D Meade; Fazle Rakib; Rafif Al-Saady; Erik Goormaghtigh; Khalid Al-Saad; Mohamed H Ali
Journal:  PLoS One       Date:  2019-02-14       Impact factor: 3.240

7.  Contribution of Raman Spectroscopy to Diagnosis and Grading of Chondrogenic Tumors.

Authors:  Mario D'Acunto; Raffaele Gaeta; Rodolfo Capanna; Alessandro Franchi
Journal:  Sci Rep       Date:  2020-02-07       Impact factor: 4.379

8.  Line Scan Raman Microspectroscopy for Label-Free Diagnosis of Human Pituitary Biopsies.

Authors:  Daniela Bovenkamp; Alexander Micko; Jeremias Püls; Fabian Placzek; Romana Höftberger; Greisa Vila; Rainer Leitgeb; Wolfgang Drexler; Marco Andreana; Stefan Wolfsberger; Angelika Unterhuber
Journal:  Molecules       Date:  2019-10-04       Impact factor: 4.411

9.  Can novel technologies improve breast conserving surgery?

Authors:  Brian W Pogue
Journal:  Breast Cancer Res       Date:  2018-08-03       Impact factor: 6.466

10.  Surface-enhanced Raman spectroscopy before radical prostatectomy predicts biochemical recurrence better than CAPRA-S.

Authors:  Jiahua Pan; Xiaoguang Shao; Yinjie Zhu; Baijun Dong; Yanqing Wang; Xiaonan Kang; Na Chen; Zhenyi Chen; Shupeng Liu; Wei Xue
Journal:  Int J Nanomedicine       Date:  2019-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.